Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 5—May 2004
Research

Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients

Jann-Tay Wang*, Wang-Huei Sheng*, Chi-Tai Fang*, Yee-Chun Chen*, Jiun-Ling Wang*, Chong-Jen Yu*, Shan-Chwen Chang*Comments to Author , and Pan-Chyr Yang*
Author affiliations: *National Taiwan University Hospital, Taipei, Taiwan

Main Article

Table 4

Complications found in 76 SARS patientsa

Complication No. of patients (%)
Rhabdomyolysis
4 (5.3)
Peripheral neuropathy
5 (6.6)
Acute renal failure
3 (3.9)
Gastrointestinal bleeding
2 (2.6)
Acute myocardial infarction
1 (1.3)
Bacteria superinfection
10 (13.2)
Candida parapsilosis superinfection
1 (1.3)
MRSA
4 (5.3)
MRSE
2 (2.6)
Enterococci
3 (3.9)
Acinetobacter baumannii
3 (3.9)
Klebsiella pneumoniae
2 (2.6)
Enterobacter cloacae
1 (1.3)
Serratia marcescense
1 (1.3)
Total 18 (23.7)

aSARS, severe acute respiratory syndrome; MRSA, methicillin-resistant Staphylococcus aureus; MRSE, methicillin-resistant Staphylococcus epidermidis. Some patients experience more than one complication.

Main Article

Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external